Dissemin is shutting down on January 1st, 2025

Published in

Taylor and Francis Group, OncoImmunology, 10(3), p. e956013

DOI: 10.4161/21624011.2014.956013

Links

Tools

Export citation

Search in Google Scholar

Inhibition of MYC in macrophages: Tumor vs Inflammation-related diseases

Journal article published in 2014 by Emilio Cano-Ramos, Begoña Lavin, Oscar M. Pello ORCID
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Inhibition of MYC has been postulated as one of the most promising anti-tumoral therapies. However, if some anti-inflammatory cells express MYC, would an anti-tumoral treatment targeting MYC facilitate subsequent inflammation-related disorders?